Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Radiographic Success of Mineral Trioxide Aggregate (MTA) vs Septodont Biodentine in Primary Molars in Pulpotomy and Indirect Pulp Cap Treatments

NCT04863222 is registered in ClinicalTrials.gov with Geisinger Clinic as lead sponsor.

NCT NCT04863222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04863222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Radiographic Success of Mineral Trioxide Aggregate (MTA) vs Septodont Biodentine in Primary Molars in Pulpotomy and Indirect Pulp Cap Treatments
Lead sponsor
Geisinger Clinic
Phase
Phase 4
Overall status
Recruiting
Start date
November 12, 2021
Completion date
December 1, 2026
Enrollment
646 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

indirect pulp cap, pulpotomy